Blockchain Registration Transaction Record

HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences

HeartBeam (BEAT) announces participation in key March 2026 investor and medical conferences to showcase its FDA-cleared 3D ECG technology and 12-lead patch prototype.

This development matters because it represents a significant leap in accessible cardiac monitoring, potentially impacting millions with heart conditions. Traditional ECG systems are often confined to clinical settings, creating barriers for timely diagnosis and continuous monitoring. HeartBeam's portable, cable-free 3D technology could democratize cardiac care by allowing accurate, 12-lead ECG data collection anywhere—at home, work, or during travel. This addresses critical gaps in managing conditions like arrhythmias, where early detection is vital for preventing strokes or heart failure. By enabling remote monitoring, it may reduce hospital visits, lower healthcare costs, and empower patients with real-time insights into their heart health. For the medical community, it offers a tool to track trends and intervene proactively, shifting cardiac care from reactive to preventive. In an aging global population with rising cardiovascular disease rates, such innovations are crucial for improving outcomes and quality of life.